[go: up one dir, main page]

WO1998033813A3 - Procede permettant d'accelerer la guerison de brulures - Google Patents

Procede permettant d'accelerer la guerison de brulures Download PDF

Info

Publication number
WO1998033813A3
WO1998033813A3 PCT/US1998/002049 US9802049W WO9833813A3 WO 1998033813 A3 WO1998033813 A3 WO 1998033813A3 US 9802049 W US9802049 W US 9802049W WO 9833813 A3 WO9833813 A3 WO 9833813A3
Authority
WO
WIPO (PCT)
Prior art keywords
analogues
aii
accelerating healing
thermal injuries
angiotensin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/002049
Other languages
English (en)
Other versions
WO1998033813A2 (fr
Inventor
Kathleen E Rodgers
Gere Dizerega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Priority to AU66500/98A priority Critical patent/AU6650098A/en
Publication of WO1998033813A2 publication Critical patent/WO1998033813A2/fr
Publication of WO1998033813A3 publication Critical patent/WO1998033813A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés et des équipements destinés à accélérer la guérison de brûlures chez des êtres humains, qui comportent l'étape consistant à appliquer sur la brûlure une quantité efficace d'angiotensinogène, d'angiotensine I (AI), d'analogues d'AI, de fragments d'AI et de ses analogues, d'angiotensine II (AII), d'analogues d'AII, de fragments d'AII ou de ses analogues, ou d'agonistes de récepteur d'AII AT2 de type 2.
PCT/US1998/002049 1997-02-04 1998-02-04 Procede permettant d'accelerer la guerison de brulures Ceased WO1998033813A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU66500/98A AU6650098A (en) 1997-02-04 1998-02-04 Method for accelerating healing of thermal injuries

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3716697P 1997-02-04 1997-02-04
US60/037,166 1997-02-04

Publications (2)

Publication Number Publication Date
WO1998033813A2 WO1998033813A2 (fr) 1998-08-06
WO1998033813A3 true WO1998033813A3 (fr) 1998-09-17

Family

ID=21892803

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/002049 Ceased WO1998033813A2 (fr) 1997-02-04 1998-02-04 Procede permettant d'accelerer la guerison de brulures

Country Status (2)

Country Link
AU (1) AU6650098A (fr)
WO (1) WO1998033813A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4347522B2 (ja) * 1997-12-12 2009-10-21 ユニバーシティ オブ サザン カリフォルニア 創傷治癒組成物
WO1999046285A2 (fr) 1998-03-11 1999-09-16 University Of Southern California Procede permettant de favoriser la production d'equivalents de tissus vivants
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
WO1999058140A1 (fr) 1998-05-11 1999-11-18 University Of Southern California Procede d'augmentation du taux de survie des globules blancs apres une chimiotherapie
CA2328871C (fr) 1998-07-13 2002-10-01 University Of Southern California Procedes permettant d'accelerer la reparation et la croissance des os et des cartilages
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
CA2339330A1 (fr) 1998-08-13 2000-02-24 University Of Southern California Procede pour augmenter le debit sanguin vers le tissu ischemique
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
ATE335496T1 (de) * 1999-03-23 2006-09-15 Univ Southern California Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
EP1252894A1 (fr) * 2001-04-26 2002-10-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de l'angiotensinogène et de ses dérivés pour la fabrication d'un médicament anti-angiogène
AU2002257970B2 (en) 2001-05-31 2007-08-02 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
CN102905719B (zh) * 2010-03-26 2015-04-22 南加利福尼亚大学 治疗复合性辐射和热损伤的方法
EP2455388A1 (fr) 2010-11-23 2012-05-23 LanthioPep B.V. Nouveaux agonistes du récepteur 2 (AT2) de type angiotensine et leurs utilisations
BR112013019513A2 (pt) 2011-02-02 2019-06-11 Univ Southern California métodos para o tratamento de úlceras diabéticas do pé
EP4007592A1 (fr) 2019-08-02 2022-06-08 LanthioPep B.V. Agonistes du récepteur de l'angiotensine 2 (at2) destinés à être utilisés dans le traitement du cancer
CN113759133A (zh) * 2020-06-05 2021-12-07 张曼 尿液血管紧张素原及其多肽片段在烧伤中的应用
CN116157065A (zh) * 2020-07-13 2023-05-23 光谱Md公司 用于伤口组织学评估的光谱成像系统和方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair
WO1995008565A1 (fr) * 1993-09-24 1995-03-30 The University Of Southern California Utilisation d'analogues d'angiotensine ii pour la reparation tissulaire
WO1995008337A1 (fr) * 1993-09-24 1995-03-30 The University Of Southern California Utilisation de l'angiotensine iii et de ses analogues pour la reparation tissulaire
WO1996014858A1 (fr) * 1994-11-14 1996-05-23 University Of Southern California Utilisation de fragments d'angiotensine ii et d'analogues de celle-ci pour la reparation des tissus
WO1996039164A1 (fr) * 1995-06-06 1996-12-12 The University Of Southern California Utilisation d'agonistes du recepteur type 2 de l'angiotensine ii dans la reparation des tissus

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair
WO1995008565A1 (fr) * 1993-09-24 1995-03-30 The University Of Southern California Utilisation d'analogues d'angiotensine ii pour la reparation tissulaire
WO1995008337A1 (fr) * 1993-09-24 1995-03-30 The University Of Southern California Utilisation de l'angiotensine iii et de ses analogues pour la reparation tissulaire
WO1996014858A1 (fr) * 1994-11-14 1996-05-23 University Of Southern California Utilisation de fragments d'angiotensine ii et d'analogues de celle-ci pour la reparation des tissus
WO1996039164A1 (fr) * 1995-06-06 1996-12-12 The University Of Southern California Utilisation d'agonistes du recepteur type 2 de l'angiotensine ii dans la reparation des tissus

Also Published As

Publication number Publication date
WO1998033813A2 (fr) 1998-08-06
AU6650098A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
WO1998033813A3 (fr) Procede permettant d'accelerer la guerison de brulures
WO1999031125B1 (fr) Compositions de cicatrisation
WO2000053211A3 (fr) Methode de stimulation de la proliferation de myocytes et de la reparation des tissus myocardiques
ZA966838B (en) Method and composition for treating asthma.
CA2199993A1 (fr) Procede d'administration de materiaux dans la peau et compositions utilisees lors de ce procede
AU2668697A (en) Method and composition for controlling formaldehyde fixation by delayed quenching
WO2003034633A3 (fr) Verification d'un code d'identification personnel reçu en ligne
GB9613986D0 (en) Ink-like or cream-like exothermic composition, exothermic device made thereof and manufacturing method of exothermic device
AU3379297A (en) Computer system architecture and method for multi-user, real-time applications
EP1275396A3 (fr) Utilisation de fragments d'angiotensine II et d'analogues de celle-ci pour la réparation des tissus
WO2000032046A3 (fr) Procede pour prevenir les atteintes physiologiques sans diminuer la photosynthese
AU2898297A (en) Use of substance p antagonists for treating social phobia
AUPP536498A0 (en) Cushioning device for footwear, footwear incorporating same and method of manufacture of cushioning device and footwear
AUPM835394A0 (en) Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
CA2323237A1 (fr) Methodes ameliorees de radiotherapie
MX202859B (en) Keratin fibre treatment composition including at least one setting polymer and at least one ceramide-type compound, and methods
DE69504780D1 (de) Nietnägel, sowie anwendungsverfahren
EP1632248B8 (fr) Anticorps Anti-Interleukin-9 ou anticorps du récepteur Anti-Interleukin-9 pour le traitment de la hyper-réponse bronchique
EP0861663A3 (fr) Agent inhibiteur des ostéoclastes comprenant l'interleukin-18
WO2001055176A3 (fr) Procedes d'inhibition de la proliferation des cellules du muscle lisse
WO2001044270A3 (fr) Procedes permettant de traiter et d'empecher des complications diabetiques
AU2779097A (en) Filtering device and method for neutralizing bad smells
WO2001043761A3 (fr) Procedes permettant de traiter et d'empecher des lesions des muqueuses
PL326246A1 (en) Composition applied at predeterminated dosis and consisting of a combination pf abiogestin enzyme transforming inhibitor and of calcium channel antagonist, method of preparing such composition and application thereof in treating cardiovascular diseases
AP9801416A0 (en) Method Of treating a plant disease.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998533204

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase